Collaboration among stakeholders is critical, and a one-stop platform is fundamental to accelerating launches and bringing efficiency.
Enter Taimei’s TrialOS platform.
As a leading digital cooperation platform for life science, Taimei Technology specializes in providing innovative technologies for clinical research and pharmacovigilance. Clinical data management solutions provided by the company include eBalance (RTSM) and eCollect (EDC), which use AI and machine learning to automate and continuously shorten study startup timelines and data management activities over time.
Taimei Technology’s eCooperate (CTMS) platform provides operational flexibility and can be used in a multi-hyphenate system with eArchives (eTMF), eCollect (EDC), and others for a centralized and secure clinical trial database. The company also provides a digitally based pharmacovigilance offering in Serious Adverse Event (eSAE) management. In addition to being GCP and GVP compliant, eSAE focuses on SAEs from collection to archiving and can reportedly reduce manual processes by almost 50%.
Taimei’s TrialOS effectively links multiple stakeholders in the pharmaceutical sector, including hospitals, drug manufacturers, regulators, and patients. The platform has been used by thousands of customers to streamline operations such as clinical research projects, clinical trial documentation, and patient data by leveraging advanced AI, big data, and cloud computing.
According to Nate Zhang, CEO of Taimei Technology US,